The Journal of Immunology, Vol 159, Issue 11 5502-5508, Copyright © 1997 by American Association of Immunologists

ARTICLES

Differential induction of DNA-binding activities following CD19 cross- linking in human B lineage cells

WK Weng, N Shah, D O'Brien, B Van Ness and TW LeBien
Department of Laboratory Medicine/Pathology, University of Minnesota Medical School, Minneapolis 55455, USA.

The B cell-specific cell surface molecule CD19 is expressed at all stages of B cell development, including normal plasma cells, and mediates signal transduction via interaction with cytoplasmic effector proteins. Cross-linking CD19 on early human B lineage cells induces the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway. To further explore the ramifications of CD19 signaling, the current study examined whether phosphorylation of Elk-1, activation of activator protein-1 (AP-1), or activation of nuclear factor-kappaB (NF-kappaB) transcription factors occurred following CD19 cross-linking. The cells used were the BLIN-1 pre-B cell line expressing low levels of cell surface mu heavy chain associated with surrogate light chain and the 1E8 immature B cell line expressing cell surface mu/kappa. Lysates from CD19 cross-linked 1E8 cells induced robust phosphorylation of an Elk-1 fusion protein in vitro, whereas no phosphorylation of Elk-1 fusion protein occurred using lysates from CD19 cross-linked BLIN-1 cells. An electrophoretic mobility shift assay employing AP-1 and NF-kappaB consensus oligonucleotides was used to demonstrate that AP-1 -binding activity increased, while constitutive NF-kappaB-binding activity was not enhanced, following 2 h of CD19 cross-linking in 1E8 cells. Supershift experiments revealed that JunD and c-Fos proteins mediated anti-CD19 induced AP-1-binding activity in 1E8 cells. In contrast, CD19 cross-linking in BLIN-1 cells resulted in the induction of NF-kappaB, but had no apparent effect on AP-1-binding activity. These data suggest that CD19-mediated signal transduction activates different transcription factors at juxtaposed stages of B cell development that may culminate in the activation or suppression of distinct sets of genes.

This article has been cited by other articles:

				R. Rangel, M. R. McKeller, J. C. Sims-Mourtada, C. Kashi, K. Cain, E. D. Wieder, J. J. Molldrem, L. V. Pham, R. J. Ford, P. Yotnda, et al. Assembly of the {kappa} PreB Receptor Requires a V{kappa}-like Protein Encoded by a Germline Transcript J. Biol. Chem., May 6, 2005; 280(18): 17807 - 17814. [Abstract] [Full Text] [PDF]

				D. C. Otero, A. N. Anzelon, and R. C. Rickert CD19 Function in Early and Late B Cell Development: I. Maintenance of Follicular and Marginal Zone B Cells Requires CD19-Dependent Survival Signals J. Immunol., January 1, 2003; 170(1): 73 - 83. [Abstract] [Full Text] [PDF]

				N. Chapal, T. Chardes, D. Bresson, M. Pugniere, J.-C. Mani, B. Pau, M. Bouanani, and S. Peraldi-Roux Thyroid Peroxidase Autoantibodies Obtained from Random Single Chain Fv Libraries Contain the Same Heavy/Light Chain Combinations as Occur in Vivo Endocrinology, November 1, 2001; 142(11): 4740 - 4750. [Abstract] [Full Text] [PDF]

				, , , , , , , , , and Human Anti-Thyroid Peroxidase Single-Chain Fragment Variable of Ig Isolated from a Combinatorial Library Assembled In-Cell: Insights into the In Vivo J. Immunol., April 15, 2000; 164(8): 4162 - 4169. [Abstract] [Full Text] [PDF]

				M. Fujimoto, J. C. Poe, P. J. Jansen, S. Sato, and T. F. Tedder CD19 Amplifies B Lymphocyte Signal Transduction by Regulating Src-Family Protein Tyrosine Kinase Activation J. Immunol., June 15, 1999; 162(12): 7088 - 7094. [Abstract] [Full Text] [PDF]

				X. Li and R. H. Carter Convergence of CD19 and B Cell Antigen Receptor Signals at MEK1 in the ERK2 Activation Cascade J. Immunol., December 1, 1998; 161(11): 5901 - 5908. [Abstract] [Full Text] [PDF]